Kafwabulula M, Ahmed K, Nagatake T, Gotoh J, Mitarai S, Oizumi K, Zumla A
Department of Internal Medicine, Institute of Tropical Medicine, Nagasaki University, Japan.
Int J Tuberc Lung Dis. 2002 Aug;6(8):732-7.
The Chest Clinic and the JICA (Japan International Cooperation Agency) Molecular Laboratories, University Teaching Hospital, Lusaka, Zambia, and the Department of Internal Medicine, Institute of Tropical Medicine, Nagasaki University, Nagasaki, Japan.
To evaluate the polymerase chain reaction (PCR) as a laboratory test for the rapid diagnosis of pulmonary tuberculosis in the African situation by identifying mycobacterial DNA in urine samples using two commonly described molecular methods.
Prospective collection and laboratory analysis of urine samples from adult Zambian patients with culture-confirmed pulmonary tuberculosis and healthy controls.
Urine was obtained from 63 patients with culture-confirmed active pulmonary tuberculosis and 63 'healthy' control patients with no active tuberculosis. DNA was isolated from urine sediment and subjected to analyses by two well-described PCR-based methods, 'the Sechi method' and 'the Githui method', for the identification of Mycobacterium tuberculosis DNA. The sensitivity and specificity of the two tests were determined.
The sensitivity and specificity of the Githui method were 55.6% (35/63) and 98.4% (62/63), respectively. The sensitivity and specificity of the Sechi method were 28.6% (18/63) and 98.4% (62/63), respectively. Of the 63 patients, 50 (79%) were HIV sero-positive and the frequency of positive PCR urines using the Githui method was greater in HIV-positive patients than in HIV-negative patients (32/50 = 64% vs. 3/13 = 23%; P = 0.05).
Neither the Githui method nor the Sechi method was sensitive enough to be recommended for routine use in clinical practice. PCR-based assays for the detection of M. tuberculosis DNA in urine will require further refinement before they can be recommended for use in clinical practice in Africa. The presence of mycobacterial DNA in urine samples of patients with pulmonary tuberculosis also requires further study.
赞比亚卢萨卡大学教学医院胸部诊所及日本国际协力机构分子实验室,以及日本长崎大学热带医学研究所内科。
通过使用两种常用的分子方法鉴定尿液样本中的分枝杆菌DNA,评估聚合酶链反应(PCR)作为一种实验室检测方法在非洲地区快速诊断肺结核的效果。
对赞比亚成年肺结核确诊患者和健康对照者的尿液样本进行前瞻性收集和实验室分析。
收集63例经培养确诊为活动性肺结核的患者和63例无活动性肺结核的“健康”对照者的尿液。从尿沉渣中提取DNA,并采用两种常用的基于PCR的方法(“塞奇法”和“吉图伊法”)进行分析,以鉴定结核分枝杆菌DNA。确定两种检测方法的敏感性和特异性。
吉图伊法的敏感性和特异性分别为55.6%(35/63)和98.4%(62/63)。塞奇法的敏感性和特异性分别为28.6%(18/63)和98.4%(62/63)。在63例患者中,50例(79%)HIV血清学检测呈阳性,使用吉图伊法检测出PCR阳性尿液的HIV阳性患者频率高于HIV阴性患者(32/50 = 64% 对 3/13 = 23%;P = 0.05)。
吉图伊法和塞奇法都不够敏感,不建议在临床实践中常规使用。基于PCR的尿液中结核分枝杆菌DNA检测方法在推荐用于非洲临床实践之前需要进一步改进。肺结核患者尿液样本中分枝杆菌DNA的存在情况也需要进一步研究。